C12N 2770/24311
Pestivirus
Official title: Pestivirus, e.g. bovine viral diarrhea virus
C12N2770/24311 (Pestivirus) appears on 166 US grants and 200 published applications in this corpus.
Search patents in C12N- Granted patents
- 166
- Published applications
- 200
- Assignees
- 122
- Inventors
- 376
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 8 | 0 |
| 1999 | 6 | 0 |
| 2000 | 4 | 0 |
| 2001 | 7 | 0 |
| 2002 | 4 | 7 |
| 2003 | 5 | 10 |
| 2004 | 3 | 10 |
| 2005 | 4 | 10 |
| 2006 | 6 | 5 |
| 2007 | 3 | 8 |
| 2008 | 12 | 10 |
| 2009 | 6 | 17 |
| 2010 | 7 | 11 |
| 2011 | 2 | 14 |
| 2012 | 4 | 9 |
| 2013 | 6 | 8 |
| 2014 | 7 | 17 |
| 2015 | 7 | 3 |
| 2016 | 12 | 13 |
| 2017 | 13 | 10 |
| 2018 | 6 | 5 |
| 2019 | 7 | 3 |
| 2020 | 3 | 4 |
| 2021 | 4 | 8 |
| 2022 | 5 | 4 |
| 2023 | 0 | 3 |
| 2024 | 2 | 7 |
| 2025 | 5 | 3 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/24334Use of virus or viral component as vaccineIndexing code102
- C12N 2770/24322New viral proteins or individual genes, new structural or functional aspects ofIndexing code97
- C12N 2770/24361Methods of inactivation or attenuationIndexing code37
- C12N 2770/24351Methods of production or purification of viral materialIndexing code13
- C12N 2770/24321Viruses as suchIndexing code12
- C12N 2770/24341Use of virus, viral particle or viral elements as a vectorIndexing code6
- C12N 2770/24371Demonstrated in vivo effectIndexing code6
- C12N 2770/24323Virus like particles [vlp]Indexing code5
All 12 subgroupsShow fewer
Recent patents
- Adjuvant compositions13 Jan 2026US 12,521,433 B2Zoetis Services LLC
- Optimized host/vector system for producing protective mono-and multivalent subunit vaccines on the basis of the yeast Kluyveromyces lactis18 Nov 2025US 12,473,562 B2Verovaccines GmbH
- Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex13 May 2025US 12,296,003 B2Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Environmentally compatible detergents for inactivation of lipid-enveloped viruses25 Mar 2025US 12,258,540 B2Takeda Pharmaceutical Company Limited
- Compositions and methods for internal controls of microvesicle isolations25 Mar 2025US 12,258,587 B2Exosome Diagnostics, Inc.
- Oral vaccine20 Aug 2026US 2026/0240985 A1WestfäLische Wilhelms-UniversitäT MüNster
- Bovine viral diarrhea virus immunogenic compositions and methods of use thereof23 Oct 2025US 2025/0325645 A1Kansas State University Research Foundation
- Immunostimulatory preparation and cosmetic, food, feed additive, and quasi-pharmaceutical product containing the immunostimulatory preparation18 Sep 2025US 2025/0288663 A1Japan Eco-Science Co., Ltd.
- Recombinant classical swine fever virus e2 protein with b/c domain swapping17 Jul 2025US 2025/0230194 A1Boehringer Ingelheim Vetmedica (China) Co., Ltd.
- Novel Adjuvant Compositions31 Oct 2024US 2024/0358825 A1Zoetis Services LLC
Most cited
By later US patents
- Recombinant infectious non-segmented negative strand RNA virus156US 6,033,886 A2000
- NYVAC vaccinia virus recombinants comprising heterologous inserts137US 5,494,807 AVirogenetics Corporation · 1996
- Modified live BRSV vaccine77US 5,733,555 AAmerican Home Products Corporation · 1998
- Modified recombinant vaccinia virus and expression vectors thereof65US 5,762,938 AVirogenetics Corporation · 1998
- Alvac canarypox virus recombinants comprising heterlogous inserts56US 5,756,103 AVirogenetics Corporation · 1998